Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

4.7%

2 terminated/withdrawn out of 43 trials

Success Rate

94.7%

+8.2% vs industry average

Late-Stage Pipeline

33%

14 trials in Phase 3/4

Results Transparency

3%

1 of 36 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

Phase 4
10(31.3%)
N/A
9(28.1%)
Phase 2
7(21.9%)
Phase 3
4(12.5%)
Phase 1
2(6.3%)
32Total
Phase 4(10)
N/A(9)
Phase 2(7)
Phase 3(4)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (43)

Showing 20 of 43 trials
NCT06551844Phase 2Recruiting

Adaptive Dengue Antiviral Platform Trial

Role: lead

NCT07543458Phase 3Not Yet Recruiting

Therapeutics for Moderate and Severe Dengue

Role: lead

NCT07468513Phase 4Recruiting

Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.

Role: collaborator

NCT04349826Phase 4Completed

The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)

Role: lead

NCT05611710Phase 2Active Not Recruiting

Anakinra in Dengue With Hyperinflammation ( AnaDen )

Role: lead

NCT03100786Phase 3Completed

Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis

Role: lead

NCT04033120Completed

Making an Early Diagnosis of Talaromycosis Using a Novel Antigen Test

Role: collaborator

NCT03092817Phase 3Completed

Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)

Role: lead

NCT06034093Not ApplicableCompleted

Real-time Artificial Intelligent (AI)-Assisted Muscle Ultrasound for Monitoring Muscle Mass Reduction in ICU Patients

Role: lead

NCT05909384Completed

Management of Sepsis in Resource Limited Settings Using a Delphi Method.

Role: lead

NCT02773407Phase 3Completed

Nepal Undifferentiated Febrile Illness Trial

Role: lead

NCT04358289Not ApplicableRecruiting

Generating Collective Solutions to Reduce Unnecessary Antibiotic Use in Vietnam

Role: lead

NCT04377451Phase 1Completed

Metformin in Dengue With Obesity

Role: lead

NCT05083130Not ApplicableCompleted

Awake Prone Positioning in Moderate to Severe COVID-19

Role: lead

NCT03854929Phase 4Completed

Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery

Role: lead

NCT03587389Phase 4Completed

Response to Rotavirus Vaccine in Infants in Ho Chi Minh City in Vietnam

Role: lead

NCT03217851Completed

Prevalence Survey of Antimalarial Drug Resistance Markers

Role: collaborator

NCT03855215Not ApplicableCompleted

Implementation of CRP Point of Care Testing in Primary Care to Improve Antibiotic Targeting in Respiratory Illness (ICAT)

Role: lead

NCT01147107Phase 4Completed

Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection

Role: collaborator

NCT04328493Phase 2Completed

The Vietnam Chloroquine Treatment on COVID-19

Role: lead